CDKN2A and glioblastoma: Lastly, MIR491 was found to be frequently codeleted with cyclin dependent kinase inhibitor 2A (CDKN2A) located on chromosome 9p21.3 in GBMs, and accordingly, the corresponding miR-491-5p and -3p expression levels were significantly lowered in GBM compared to in the normal brain.